Krystal Biotech (KRYS)
(Delayed Data from NSDQ)
$177.78 USD
-4.94 (-2.70%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $177.92 +0.14 (0.08%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $0.46 | 0.00% |
Earnings Summary
For their last quarter, Krystal Biotech (KRYS) reported earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.20 per share. This reflects a negative earnings surprise of 85.00%. Look out for KRYS's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of $0.46 per share, reflecting a year-over-year increase of 136.8%.
Earnings History
Price & Consensus
Zacks News for KRYS
Roche (RHHBY) NSCLC Drug Alecensa Gets EC Nod for Label Expansion
KRYS: What are Zacks experts saying now?
Zacks Private Portfolio Services